According to a new report by UnivDatos Market Insights, the Pulmonary Arterial Hypertension Market is expected to reach USD 11.5 Billion in 2032 by growing at a CAGR of ~5%. The uncommon and progressive condition known as pulmonary arterial hypertension (PAH) is typified by elevated blood pressure in the pulmonary arteries, which transport blood from the heart to the lungs. These arteries...